PharmaEssentia Innovation Research Center News and Activities

PharmaEssentia Innovation Research Center is owned by PharmaEssentia.

PharmaEssentia is a company listed under the stock ticker 6446 (TW).

PharmaEssentia has a direct presence in 3 countries.

PharmaEssentia has 3 subsidiaries including PharmaEssentia Innovation Research Center, PharmaEssentia Japan and PharmaEssentia USA.

They are in:

• Pharmaceuticals50%
• Biotechnology50%

View the org chart displaying its 5 main executives

Most searched biographies at PharmaEssentia Innovation Research Center

• Kuan-Chun Huang, Senior Director of Pharmacology and Translational...
• Erik Sampson, Director of Translational Pharmacology
• Ming-Tang Chen, Senior Director of Biologics Platform

Create your alert
to follow the executive moves at PharmaEssentia Innovation Research Center.

PharmaEssentia has 2,405 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ona Therapeutics has just announced a $87 Million fundraising (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Carl Gordon - Director at Odyssey Therapeutics

Learn more about the Biotechnology industry

Press releases by PharmaEssentia Innovation Research Center

Social media about PharmaEssentia Innovation Research Center

• PharmaEssentia Innovation Research Center on Wikipedia, Google News & Yahoo Finance
• PharmaEssentia Innovation Research Center on LinkedIn, X (Twitter) & YouTube